Ornim Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Ornim Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6417
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ornim Inc (Ornim) is a medical device company that specializes in clinical research, development and distribution of medical devices in the field of tissue and cerebral blood flow and perfusion, among others. The company’s c-FLOW is a continuous non-invasive monitor of deep tissue blood flow that is used to measure relative changes in blood flow. Its UTlight technology employs a grouping of light and ultrasound to provide a non-invasive measure of regional blood flow. Ornim’s products find applications in cardiac surgery and neurological treatments, among others. The company has presence in the US and Israel. Ornim is headquartered in Foxboro, Massachusetts, the US.

Ornim Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ornim Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ornim Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ornim Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ornim Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Ornim Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ornim Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Ornim Raises USD20 Million in Series C Venture Financing 10
Ornim Medical Raises US$10 Million In Extended Series B Financing 11
Ornim Raises US$20 Million In Series B Financing 13
OrNim Medical Secures USD20 Million in Series B Funding 15
Ornim Inc – Key Competitors 16
Ornim Inc – Key Employees 17
Ornim Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Ornim Inc, Medical Equipment, Key Facts 2
Ornim Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Ornim Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ornim Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ornim Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ornim Inc, Deals By Market, 2012 to YTD 2018 8
Ornim Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ornim Raises USD20 Million in Series C Venture Financing 10
Ornim Medical Raises US$10 Million In Extended Series B Financing 11
Ornim Raises US$20 Million In Series B Financing 13
OrNim Medical Secures USD20 Million in Series B Funding 15
Ornim Inc, Key Competitors 16
Ornim Inc, Key Employees 17
Ornim Inc, Subsidiaries 18

List of Figures
Ornim Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Ornim Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Ornim Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Ornim Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Ornim Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ornim Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Ornim Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ornim Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Ornim Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Patria Oyj:企業の戦略・SWOT・財務情報
    Patria Oyj - Strategy, SWOT and Corporate Finance Report Summary Patria Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Vitabiotics Ltd:企業の戦略的SWOT分析
    Vitabiotics Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • PT Perusahaan Gas Negara (Persero) Tbk (PGAS):石油・ガス:M&Aディール及び事業提携情報
    Summary PT Perusahaan Gas Negara (Persero) Tbk (PGN) is a downstream energy that transmits and distributes natural gas. The company plans, constructs and develops downstream natural gas businesses and carries out processing, transportation, storage and trading of natural gas. It produces, trades and …
  • McWane, Inc.:企業の戦略・SWOT・財務分析
    McWane, Inc. - Strategy, SWOT and Corporate Finance Report Summary McWane, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Nightstar Therapeutics PLC (NITE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nightstar Therapeutics PLC (Nightstar Therapeutics), formerly Nightstar Therapeutics Ltd, is a clinical-stage gene therapy company. The company focus on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases. Its lead product cand …
  • Exelon Generation Company LLC:企業の戦略的SWOT分析
    Exelon Generation Company LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Albemarle Corporation:戦略・SWOT・企業財務分析
    Albemarle Corporation - Strategy, SWOT and Corporate Finance Report Summary Albemarle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Presidio Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Presidio Pharmaceuticals Inc (Presidio Pharmaceuticals) is a clinical-stage pharmaceutical company that discovers, develops, and supplies small-molecule antiviral therapeutics. The company’s products include HCV NS5A, protease inhibitor, ravidasvir hydrochloride, NS5B proteins, lead pan-geno …
  • HDR Inc:企業の戦略的SWOT分析
    HDR Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Alabama Municipal Electric Authority:企業の戦略的SWOT分析
    Alabama Municipal Electric Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Ishihara Sangyo Kaisha Ltd (4028):企業の財務・戦略的SWOT分析
    Ishihara Sangyo Kaisha Ltd (4028) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Deutsche Borse Ag
    Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hanwha Q CELLS Co Ltd (HQCL):電力:M&Aディール及び事業提携情報
    Summary Hanwha Q CELLS Co Ltd (Q CELLS) is a vertically integrated solar solution provider. It develops, manufactures and sells solar cells and modules. The company produces a wide range of PV cells and modules, and silicon ingots; and provides EPC services for the development and installation of gr …
  • Hexicon AB:電力:M&Aディール及び事業提携情報
    Summary Hexicon AB (Hexicon) is a design and engineering company that manufactures and develops floating multi-platforms for offshore wind energy production. The company offers utilities to the developers for managing and utilizing the power of offshore wind and Hexicon platforms, and provides tank …
  • NuvOx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NuvOx Pharma LLC (NuvOx Pharma) is a biotechnology company that develops oxygen therapeutics for the treatment of human diseases. The company develops novel therapies and formulations based on dodecafluoropentane emulsion platform. Its pipeline products include compounds such as NVX-108, NVX …
  • Softchoice Corporation:企業の戦略的SWOT分析
    Softchoice Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Marmen Inc:企業の戦略的SWOT分析
    Marmen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Culture Landmark Investment Ltd
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Full House Resorts, Inc.:企業の戦略・SWOT・財務情報
    Full House Resorts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Full House Resorts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sodexo SA:企業の戦略・SWOT・財務情報
    Sodexo SA - Strategy, SWOT and Corporate Finance Report Summary Sodexo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆